Citations

Showing 10 of 108081 citations.

Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience
Gamez, Mauricio E. , Halyard, Michele Y. , Wong, William W. , Vargas, Carlos , Foote, Robert L. , Patel, Samir H. , Ma, Daniel, Ko, Stephen J. , Lal, Devyani , Daniel, J.

Mayo Clinic

Head & Neck | May 31, 2017 | Volume: 39 | Issue: 9 | Pages: 1819-1824

10.1002/hed.24834 | PMID 28561906 Get It

Medical Students Call for Single-Payer National Health Insurance
Harrison, Andrew M. , Harrison, Andrew Marc

Mayo Clinic

Academic Medicine | May 31, 2017 | Volume: 92 | Issue: 6 | Pages: 735-735

10.1097/acm.0000000000001699 | PMID 28557929 Get It

Living with Ultra-Low Vision: An Inventory of Self-Reported Visually Guided Activities by Individuals with Profound Visual Impairment
Adeyemo, Olukemi, Jeter, Pamela E. , Rozanski, Collin, Arnold, Ellen, Swenor, Bonnielin K. , Group, PLoVR Study, Dalvin, Lauren A. , Dagnelie, Gislin , Group, PLoVR Study

Mayo Clinic

Translational Vision Science & Technology | May 31, 2017 | Volume: 6 | Issue: 3 | Pages: 10

10.1167/tvst.6.3.10 | PMID 28573074 Get It

Benefit of Cardiopoietic Mesenchymal Stem Cell Therapy on Left Ventricular Remodelling: Results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) Study
Metra, Marco , Filippatos, Gerasimos , Povsic, Thomas J. , Henry, Timothy D. , Alexandre, Bertrand, Homsy, Christian, Edwards, Christopher , Seron, Aymeric, Wijns, William , Investigators, for the CHART, Teerlink, John R , Davison, Beth A. , Bartúnek, Jozef , Terzic, André , Gersh, Bernard J. , Cotter, Gad , Investigators, for the CHART, Metra, Marco , Wijns, William

Mayo Clinic

European Journal of Heart Failure | May 31, 2017 | Volume: 19 | Issue: 11 | Pages: 1520-1529

10.1002/ejhf.898 | PMID 28560782 Get It

Abstract Aims Left ventricular (LV) reverse remodelling is an important marker of improved outcomes in patients with advanced heart failure (HF). We examined the impact of the intramyocardial administration of bone-marrow-derived, lineage-directed, autologous cardiopoietic mesenchymal stem cells (C3BS-CQR-1) on LV remodelling in patients with advanced HF enrolled in the CHART-1 study. Methods and results Patients (n=351) with symptomatic advanced HF secondary to ischaemic heart disease, and reduced LV ejection fraction (LVEF <35%) were randomized to receive C3BS-CQR-1 or a sham procedure. In a post hoc analysis we examined the effect of C3BS-CQR-1 on LV reverse remodelling within 1 year of the procedure and the influence of C3BS-CQR-1 dosing in the 271 patients treated as randomized. Delivery of C3BS-CQR-1 was associated with a progressive decrease in both LV end-diastolic volume (LVEDV) and end-systolic volume (LVESV) within 52 weeks after treatment. At 1 year, the LVEDV and LVESV of treated patients decreased by 17.0 mL and 12.8 mL greater than controls (P=0.006 and P=0.017, respectively). The effect on LVEDV was maintained after multivariable adjustment for baseline age, systolic blood pressure, LVEDV, LVEF and history of myocardial infarction. The largest reverse remodelling was evident in the patients receiving a moderate number of injections (<20). Conclusion In CHART-1, intramyocardial administration of cardiopoietic stem cells led to reverse remodelling as evidenced by significant progressive decreases in LVEDV and LVESV through the 52 weeks of follow-up. Further studies are needed to explore the dose response with regard to cell number and injected volume, and reverse remodelling.
Clinical presentation and echocardiographic diagnosis of postinfarction papillary muscle rupture: A review of 22 cases
Ternus, Bradley W. , Mankad, Sunil , Edwards, William D. , Mankad, Rekha , Mankad, Rekha

Mayo Clinic

Echocardiography | May 31, 2017 | Volume: 34 | Issue: 7 | Pages: 973-977

10.1111/echo.13585 | PMID 28560714 Get It

BackgroundAcute myocardial infarctions (AMI) continue to be common in the United States. Mechanical complications of AMI can lead to cardiogenic shock (CS) and death. The aim of this study was to review the cases of papillary muscle ruptures in the setting of myocardial infarctions at a tertiary care center, with a focus on the clinical presentation and echocardiographic diagnosis.MethodsThis was a retrospective study from January 1, 2000 through December 31, 2014. In all, 22 patients with AMI and papillary muscle rupture (AMI‐PMR) who had surgical intervention were identified.ResultsThe average age was 70 (±11) with 16 (73%) males. Six patients presented with ST‐elevation myocardial infarctions (STEMI) and all underwent emergent revascularization with primary percutaneous coronary intervention (PCI) prior to the diagnosis of AMI‐PMR. The other 16 patients presented with a non‐STEMI. In total, 17 (77%) of the 22 patients were diagnosed with an AMI‐PMR within 7 days from their onset of symptoms. In all, 12 patients (55%) had anterolateral papillary muscle ruptures (ALPMR), and the other 10 had posteromedial papillary muscle ruptures (PMPMR). Ruptures were complete in 10 patients (45%). Patients presented with pulmonary edema early (<7 days) more commonly than late (>14 days). Transthoracic echocardiography was able to demonstrate severe mitral regurgitation in 86% and a definitive or suggestive diagnosis in 93%. All 22 patients survived to operative management, and the overall in‐hospital mortality rate was 9%.ConclusionIn conclusion, ischemic papillary muscle ruptures continue to occur, but with prompt diagnosis by echocardiography and rapid surgical management, the mortality rate continues to decline.
Response to Drs Von Hoff and Renschler
Ahn, Daniel H. , Bekaii‐Saab, Tanios , Bekaii-Saab, Tanios S

Mayo Clinic

Therapeutic Advances in Medical Oncology | May 31, 2017 | Volume: 9 | Issue: 6 | Pages: 445-446

10.1177/1758834017709238 | PMID 28607583 Get It

Engineered CRISPR Systems for Next Generation Gene Therapies
Pineda, Michael , Moghadam, Farzaneh , Ebrahimkhani, Mo R. , Kiani, Samira , Pineda, Michael

Mayo Clinic

ACS Synthetic Biology | May 30, 2017 | Volume: 6 | Issue: 9 | Pages: 1614-1626

10.1021/acssynbio.7b00011 | PMID 28558198 Get It

Linking Amyloid-β and Tau Deposition in Alzheimer Disease
Vemuri, Prashanthi , Schöll, Michael , Vemuri, Prashanthi , Schöll, Michael

Mayo Clinic

JAMA Neurology | May 30, 2017 | Volume: 74 | Issue: 7 | Pages: 766

10.1001/jamaneurol.2017.0323 | PMID 28558092 Get It

Gastrointestinal: Multiparametric hybrid 18‐FDG PET/MRI evaluation of gastric adenocarcinoma
Broski, S. M., Johnson, Geoffrey B. , Goenka, AH, Broski, Stephen M. , Johnson, Geoffrey B

Mayo Clinic

Journal of Gastroenterology and Hepatology | May 30, 2017 | Volume: 32 | Issue: 6 | Pages: 1132-1132

10.1111/jgh.13631 | PMID 28557202 Get It

Hyponatremia in the perioperative period: When and how to correct
Leise, Michael D. , Findlay, James Y.

Mayo Clinic

Clinical Liver Disease | May 30, 2017 | Volume: 9 | Issue: 5 | Pages: 111-114

10.1002/cld.630 | PMID 30992972 Get It